NYMOX PHARMACEUTICAL CORP Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NYMOX PHARMACEUTICAL CORP for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.02 | 2,000 | 8,040 | 3,046,050 | 3 M to 3 M (+0.07 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.01 | 1,000 | 4,010 | 3,044,050 | 3 M to 3 M (+0.03 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.00 | 500 | 2,000 | 3,043,050 | 3 M to 3 M (+0.02 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.16 | 2,000 | 8,320 | 3,042,550 | 3 M to 3 M (+0.07 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.15 | 500 | 2,075 | 3,040,550 | 3 M to 3 M (+0.02 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.14 | 2,500 | 10,350 | 3,040,050 | 3 M to 3 M (+0.08 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.07 | 500 | 2,035 | 3,037,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.05 | 500 | 2,025 | 3,037,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.04 | 1,000 | 4,040 | 3,036,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.00 | 1,500 | 6,000 | 3,035,550 | 3 M to 3 M (+0.05 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.92 | 1,000 | 3,920 | 3,034,050 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.91 | 500 | 1,955 | 3,033,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.74 | 900 | 3,366 | 3,032,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.73 | 600 | 2,238 | 3,031,650 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.65 | 500 | 1,825 | 3,031,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.59 | 1,000 | 3,590 | 3,030,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.58 | 500 | 1,790 | 3,029,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.57 | 500 | 1,785 | 3,029,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.56 | 600 | 2,136 | 3,028,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.55 | 400 | 1,420 | 3,027,950 | 3 M to 3 M (+0.01 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 5,000 | 18,850 | 3,027,550 | 3 M to 3 M (+0.17 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 1,000 | 3,770 | 3,022,550 | 3 M to 3 M (+0.03 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.76 | 3,500 | 13,160 | 3,021,550 | 3 M to 3 M (+0.12 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.75 | 500 | 1,875 | 3,018,050 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 500 | 1,895 | 3,017,550 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 2,200 | 8,294 | 3,017,050 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.76 | 300 | 1,128 | 3,014,850 | 3 M to 3 M (+0.01 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.75 | 2,000 | 7,500 | 3,014,550 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.80 | 1,900 | 7,220 | 3,012,550 | 3 M to 3 M (+0.06 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 2,000 | 7,580 | 3,010,650 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.78 | 500 | 1,890 | 3,008,650 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 600 | 2,262 | 3,008,150 | 3 M to 3 M (+0.02 %) |